16409461

Source:http://linkedlifedata.com/resource/pubmed/id/16409461

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0015520, umls-concept:C0021467, umls-concept:C0021469, umls-concept:C0040508, umls-concept:C0439851, umls-concept:C0442027, umls-concept:C1552596, umls-concept:C1611967, umls-concept:C1708528, umls-concept:C1861172, umls-concept:C1947931
pubmed:issue	1
pubmed:dateCreated	2006-1-13
pubmed:abstractText	Joint replacement surgery is an appropriate model for dose-ranging studies investigating new anticoagulants.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101170508
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Enoxaparin, http://linkedlifedata.com/resource/pubmed/chemical/Factor Xa, http://linkedlifedata.com/resource/pubmed/chemical/Morpholines, http://linkedlifedata.com/resource/pubmed/chemical/Thiophenes, http://linkedlifedata.com/resource/pubmed/chemical/rivaroxaban
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1538-7933
pubmed:author	pubmed-author:BorrisLL, pubmed-author:DahlO EOE, pubmed-author:ErikssonB IBI, pubmed-author:HaasSS, pubmed-author:HuismanM VMV, pubmed-author:KäleboPP, pubmed-author:KakkarA KAK, pubmed-author:MisselwitzFF, pubmed-author:ODIXa-HIP Study Investigators
pubmed:issnType	Print
pubmed:volume	4
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	121-8
pubmed:dateRevised	2009-2-10
pubmed:meshHeading	pubmed-meshheading:16409461-Adult, pubmed-meshheading:16409461-Aged, pubmed-meshheading:16409461-Aged, 80 and over, pubmed-meshheading:16409461-Anticoagulants, pubmed-meshheading:16409461-Arthroplasty, Replacement, Hip, pubmed-meshheading:16409461-Dose-Response Relationship, Drug, pubmed-meshheading:16409461-Double-Blind Method, pubmed-meshheading:16409461-Enoxaparin, pubmed-meshheading:16409461-Factor Xa, pubmed-meshheading:16409461-Female, pubmed-meshheading:16409461-Hemorrhage, pubmed-meshheading:16409461-Humans, pubmed-meshheading:16409461-Male, pubmed-meshheading:16409461-Middle Aged, pubmed-meshheading:16409461-Morpholines, pubmed-meshheading:16409461-Postoperative Complications, pubmed-meshheading:16409461-Pulmonary Embolism, pubmed-meshheading:16409461-Thiophenes, pubmed-meshheading:16409461-Thromboembolism, pubmed-meshheading:16409461-Venous Thrombosis
pubmed:year	2006
pubmed:articleTitle	Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement.
pubmed:affiliation	Sahlgrenska University HospitalOstra, Gothenburg, Sweden. b.eriksson@orthop.gu.se
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study